Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter February 24, 2022

Datura stramonium abrogates depression- and anxiety-like disorders in mice: possible involvement of monoaminergic pathways in its antidepressant activity

  • Murtala A. Akanji EMAIL logo , Oyinloye O. Elijah , Alabi A. Oyedolapo , Aderionla A. Aderonke , Ogunjimi L. Opeoluwa , Adesina A. Omoloye , Farouk A. Oladoja , Shonde O. Olatundun and Osipitan L. Edatomolaosi

Abstract

Objectives

Ethno-botanical surveys uncovered the use of Datura stramonium in the management of mental health abnormalities. Antidepressant- and anxiolytic-like activities of hydroethanol leaf extract of D. stramonium (HLDS) in mice and its possible mechanism of action were investigated in this study.

Methods

The hole-board test (HBT), open field test (OFT), elevated plus maze test (EPMT), and social interaction test (SIT) were used to investigate the anxiolytic-like activity while forced swim test (FST) and tail suspension test (TST) were employed for the antidepressant effect. Mice were pre-treated orally with purified water (10 mL/kg), bromazepam (1 mg/kg), fluoxetine (20 mg/kg) and D. stramonium (25, 50, 100 and 200 mg/kg). One hour post-treatment, mice were subjected to the various tests.

Results

In HBT, D. stramonium increased the head dips and sectional crossings turnover. D. stramonium increased the number of square crossed and rearings/assisted rearings in OFT. DS increased the time spent in open arms of EPM. In SIT, D. stramonium increased the frequency/duration of interactions. In FST and TST, D. stramonium decreased the duration of immobility which were reversed by doxazosin (α1 adrenoceptor antagonist) and ondasentron (5-HT3 receptor antagonist).

Conclusions

HLDS has anxiolytic- and antidepressant-like activities through modulation of serotoninergic and adrenergic neurotransmissions.


Corresponding author: Murtala A. Akanji, Department of Pharmacology and Toxicology, Faculty of Basic Medical Sciences, Obafemi Awolowo College of Health Sciences, Olabisi Onabanjo University, Ago-Iwoye, Nigeria, Phone: +234 8037983157, E-mail:

Acknowledgments

The authors would like to appreciate the contributions of Dr Ishola of University of Lagos, Nigeria for his scientific advise. Authors also appreciate Mr Osipitan Luqman for his hard work.

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission. All authors involved at every stage of this research work.

  3. Competing interests: There was no case of conflicting interests among authors).

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: Ethical approval was obtained from the Health Research Ethics Committee (HREC) of college of medicine, university of Lagos, Nigeria. The guidelines of National Institutes of Health (NIH) for the handling of Laboratory Animals were adhered to.

References

1. Rehm, J, Shield, KD. Global burden of disease and the impact of mental and addictive disorders. Curr Psychiatr Rep 2019;21:10. https://doi.org/10.1007/s11920-019-0997-0.Search in Google Scholar PubMed

2. Hannah, R, Max, R. Mental health. Our world in data; 2018 [Online]. Available from: https://ourworldindata.org/mental-health.Search in Google Scholar

3. World Health Organization. Depression and Other Common Mental Disorders. Global Health Estimates. Switzerland: WHO press Geneva; 2020.Search in Google Scholar

4. Gregor, H. Pathophysiology of depression: do we have any solid evidence of interest to clinicians? World Psychiatry 2010;9:155–61.10.1002/j.2051-5545.2010.tb00298.xSearch in Google Scholar PubMed PubMed Central

5. Sullivan, PF, Neale, MC, Kendler, KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 2000;157:1552–62. https://doi.org/10.1176/appi.ajp.157.10.1552.Search in Google Scholar PubMed

6. Hasler, G, van der Veen, JW, Tumonis, T, Meyers, N, Shen, J, Drevets, WC. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatr 2007;64:193–200. https://doi.org/10.1001/archpsyc.64.2.193.Search in Google Scholar PubMed

7. Carla, N, Linda, A, Nandie, B, Marizél, K, Maggy, L, Jurgens, N, et al.. Anxiety disorders: psychiatric comorbidities and psychosocial stressors among adult outpatients. S Afr J Psychol 2018;24:a1138.10.4102/sajpsychiatry.v24i0.1138Search in Google Scholar PubMed PubMed Central

8. Baslet, G, Seshadri, A, Bemeo-Ovalle, A, Willment, K, Myers, L. Psychogenic non-epileptic seizures: an update primer. Psychosom 2016;57:1–17. https://doi.org/10.1016/j.psym.2015.10.004.Search in Google Scholar PubMed

9. Groen, RN, Oisin, R, Johanna, JWW, Harriette, R, Brenda, WJHP, Erik, JG, et al.. Co-morbidity between depression and anxiety: assessing the role of bridge mental status in dynamic psychological networks. BMC Med 2020;18:308. https://doi.org/10.1186/s12916-020-01738-z.Search in Google Scholar PubMed PubMed Central

10. Ned, H, Kalin, MD. The critical relationship between anxiety and depression. Am J Psychiatry 2020;177:365–7. https://doi.org/10.1176/appi.ajp.2020.20030305.Search in Google Scholar PubMed

11. Akinsulore, A, Adeseiye, OC, Oloniniyi, IO, Esimai, OA. Prevalence and factors associated with co-morbid depression and anxiety among older adults in South-Western Nigeria: a community-based study. Annals Health Res 2020;6:421–31. https://doi.org/10.30442/ahr.0604-07-105.Search in Google Scholar

12. Francky, TE, Ngou, ML, Jean, JB. Epidemiology of depressive disorders in people living with hypertension in Africa: a systematic review and meta-analysis. BMJ Open 2020;10: e037975. https://doi.org/10.1136/bmjopen-2020-037975.Search in Google Scholar PubMed PubMed Central

13. Agegnehu, B, Abera, M, Zerihun, Z, Biresaw, W, Tomas, Y. Comorbid anxiety and depression: prevalence and associated factors among pregnant women in Arba Minch Zuria district, Gamo zone, southern Ethiopia. PLoS One 2021;16:e0248331.10.1371/journal.pone.0248331Search in Google Scholar

14. Garakani, A, Murrough, JW, Freire, RC, Thom, RP, Larkin, K, Buono, FD, et al.. Pharmacotherapy of anxiety disorders: current and emerging treatment options. Front Psychiatry 2020;1412. https://doi.org/10.3389/fpsyt.2020.595584.Search in Google Scholar

15. Borwin, B, Sophie, M, Dirk, W. Treatment of anxiety disorders. Dialogues Clin Neurosci 2017;19:93–107.10.31887/DCNS.2017.19.2/bbandelowSearch in Google Scholar

16. Jarald, E, Edwin, S. Textbook of pharmacognosy and phytochemisctry, 1st ed. New Dehli: CBS Publisher and Distributors; 2007:224 p.Search in Google Scholar

17. Glatstein, M, Alabdulrazzaq, F, Scolnik, D. Belladonna alkaloid intoxication. Am J Therapeut 2016;23:e74–7. https://doi.org/10.1097/01.mjt.0000433940.91996.16.Search in Google Scholar

18. Soni, P, Siddiqui, AA, Dwivedi, J, Soni, V. Pharmacological properties of Datura stramonium L. as a potential medicinal tree: an overview. Asian Pac J Trop Biomed 2012;2:1002–8. https://doi.org/10.1016/S2221-1691(13)60014-3.Search in Google Scholar

19. Maria, NM, Mourine, K, Christine, B. Qualitative and quantitative phytochemical profiling of crude fractions of Pechuel-Loeschea leubnitziae leaves. J Med Plants Res 2021;15:64–72. https://doi.org/10.5897/jmpr2020.7073.Search in Google Scholar

20. Oladotun, PB, Anuoluwa, AA, Alaba, OA, Akan, BW, Nsikak, UB. Dataset on phytochemical screening, FTIR and GC–MS characterisation of Azadirachta indica and Cymbopogon citratus as reducing and stabilising agents for nanoparticles synthesis. J Data Brief 2018;20:917–26.10.1016/j.dib.2018.08.133Search in Google Scholar PubMed PubMed Central

21. Shahed, AM, Shah, MML. Evaluation of sedative and anxiolytic activities of methanol extract of leaves of Persicaria hydropiper in mice. Clin Phytosci 2017;3:20. https://doi.org/10.1186/s40816-017-0056-5.Search in Google Scholar

22. Kraeuter, AK, Guest, PC, Sarnyai, Z. The open field test for measuring locomotor activity and anxiety-like behavior. In Pre-clinical models, Humana Press, New York, NY 2019;99–103.10.1007/978-1-4939-8994-2_9Search in Google Scholar PubMed

23. Seibenhener, ML, Wooten, MC. Use of the open field maze to measure locomotor and anxiety-like behaviour in mice. J Vis Exp 2015;96:e52434. https://doi.org/10.3791/52434.Search in Google Scholar PubMed PubMed Central

24. Salako, OA, Akindele, AJ, Balogun, AO, Adeyemi, OO. Investigation of antidepressant, anxiolytic and sedative activities of the aqueous leaf extract of Musa sapientum Linn. (Banana; Musaceae). Drug Res 2018;68:1–8. https://doi.org/10.1055/a-0651-7978.Search in Google Scholar PubMed

25. Akindele, AJ, Hakeem, AS, Pamela, CE. Anxiolytic activity of aerial part hydroethanolic extract of Allium ascalonicum Linn. (Liliaceae) in mice. Funct Foods Health Dis 2012;2:448–59. https://doi.org/10.31989/ffhd.v2i11.71.Search in Google Scholar

26. Common, KG, Cholanians, AB, Babb, JA, Ehlinger, DG. The rodent forced swim test measures stress-coping strategy, not depression-like behaviour. ACS Chem Neurosci 2017;8:955–60. https://doi.org/10.1021/acschemneuro.7b00042.Search in Google Scholar PubMed PubMed Central

27. Yousuf, S, Shiekh, MH, Akhtar, R, Muhammad, Z, Marlia, MH, Huda, N, et al.. Evaluation of antidepressant activity of methanolic and hydroalcoholic extracts of Acorus calamus L. rhizome through tail suspension test and forced swimming test of mice. J Tradit Chin Med Sci 2020;7:301–7. https://doi.org/10.1016/j.jtcms.2020.07.002.Search in Google Scholar

28. Goncalves, FM, Neis, VB, Rieger, DK, Peres, TV, Lopez, MW, Heinrich, IA, et al.. Glutamatergic system and mTOR signalling pathway participate in the antidepressant-like effect of inosin in the tail suspension test. J Neural Transm 2017;124:1227–37. https://doi.org/10.1007/s00702-017-1753-4.Search in Google Scholar PubMed

29. Murtala, AA, Akindele, AJ. Anxiolytic- and antidepressant-like activities of hydroethanol leaf extract of Newbouldia laevis (P. Beauv.) Seem. (Bignoniaceae) in mice. J Ethnopharmacol 2019;249:112420. https://doi.org/10.1016/j.jep.2019.112420.Search in Google Scholar PubMed

30. Ebert, B, Wafford, KA, Deacon, S. Treating insomnia: current and investigational pharmacological approaches. Pharmacol Therap 2006;112:612–29.10.1016/j.pharmthera.2005.04.014Search in Google Scholar PubMed

31. Adebiyi, OE, Funmilayo, EO, James, OO, Funsho, OO. Behavioural studies on the ethanol leaf extract of Grewia carpinifolia in Wistar rats. Afr Health Sci 2016;16:339–46. https://doi.org/10.4314/ahs.v16i1.45.Search in Google Scholar PubMed PubMed Central

32. Hafiz, MA, Abdul, H, Muhammad, RA, Khalid, A, Abdul, SH. Dose-Dependent, antidepressant, and anxiolytic effects of a traditional medicinal plant for the management of behavioral dysfunctions in animal models. Dose-Response 2019;17:1–6.10.1177/1559325819891262Search in Google Scholar

33. Arika, WM, Kibiti, CM, Njagi, JM, Mathew, JM, Ngugi, MP. Effects of DCM leaf extract of Gnidia glauca (fresen) on locomotor activity, anxiety and exploration-like behaviors in high fat diet-induced obese rats. Behav Neurol 2019. https://doi.org/10.1155/2019/7359235.Search in Google Scholar PubMed PubMed Central

34. Schneider, P, Ho, YJ, Spanagel, R, Pawlak, CR. A novel elevated plus-maze procedure to avoid the one-trial tolerance problem. Front Behav Neurosci 2011;5:43. https://doi.org/10.3389/fnbeh.2011.00043.Search in Google Scholar PubMed PubMed Central

35. Malkhaz, M, Giorgi, A, Tamila, B, Tea, G, Ketevan, G, Tamar, N, et al.. The anxiolytic effect of some plant extracts in clinical trials and animal models. World J Bio Pharm Health Sci 2021;05:038–43. https://doi.org/10.30574/wjbphs.2021.5.3.0023.Search in Google Scholar

36. Hossain, MM, Aka, TD, Rahman, MS, Uddin, AM, Rahman, N, Rashid, MM. Neuropharmacological activity of the crude ethanolic extract of Syzygium aromaticum flowering bud. Discov Phytomedicine 2019;6:191–8.10.15562/phytomedicine.2019.109Search in Google Scholar

37. Tiwari, A, Rathi, J, Sandeep, KD, Sanno, ST. Evaluation of anti-anxiety activity of Datura leaves in mice. Int J Indig Herbs Drugs 2018;3:23–4.Search in Google Scholar

38. Egashira, N, Tanoue, A, Matsuda, T. Impaired social interaction and reduced anxiety-related behavior in vasopressin V1a receptor knockout mice. Behav Brain Res 2007;178:123–7. https://doi.org/10.1016/j.bbr.2006.12.009.Search in Google Scholar PubMed

39. Oksana, KB, Tatiana, L, Igor, V, John, R, James, RW. Assessment of social interaction behaviors. Neuroscience 2011. https://doi.org/10.3791/2473.Search in Google Scholar PubMed PubMed Central

40. Donatus, WA, Priscilla, K, Kennedy, KEK, Elvis, OA, Eric, W, Iliya, HA. Anxiolytic-like effect of the leaves of Pseudospondias micricarpa (A. Rich.) Engl. in mice. J Basic Clin Physiol Pharmacol 2016;27:533–46.10.1515/jbcpp-2015-0067Search in Google Scholar

41. Roni, YY, Motty, F, Avrham, H, Ravid, D. The forced swim test as a model of depressive-like behavior. J Vis Exp 2015;97:52587. https://doi.org/10.3791/52587.Search in Google Scholar PubMed PubMed Central

42. Cryan, JF, Cedric, M, Annick, V. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 2005;29:571–625. https://doi.org/10.1016/j.neubiorev.2005.03.009.Search in Google Scholar PubMed

43. Krotulski, AJ, Chapman, BP, Marks, SJ, Ontiveros, ST, Devin-Holcombe, K, Fogarty, MF, et al.. Sentanyl: a comparison of blood fentanyl concentrations and naloxone dosing after non-fatal overdose. Clin Toxicol 2021;60:1–8. https://doi.org/10.1080/15563650.2021.1948558.Search in Google Scholar PubMed

44. Nasiara, K, Imran, K, Abeer, A, Ajmal, K, Sobia, AH. Antidepressant potential of novel flavonoids derivatives from sweet violet (Viola odorata L): pharmacological, biochemical and computational evidences for possible involvement of serotonergic mechanism. Fitoterapia 2018;128:148–61.10.1016/j.fitote.2018.05.016Search in Google Scholar PubMed

45. Xiao, WZ, Zhou, WH, Ma, Q, Cui, WG, Mei, QY, Zhao, X. Serotonergically dependent antidepressant-like activity on behavior and stress axis responsivity of acacetin. Pharmac Res 2019;146:104310. https://doi.org/10.1016/j.phrs.2019.104310.Search in Google Scholar PubMed

46. Priyanka, P, Rajesh, KG. Antidepressant-like effect of a standardized hydroethanolic extract of Asparagus adscendens in mice. Indian J Pharmacol 2019;50:98–108.10.4103/ijp.IJP_116_17Search in Google Scholar

47. Muhammad, AR, Rafeeq, AK. Phytochemical screening, acute toxicity, anxiolytic and antidepressant activities of the Nelumbo nucifera fruit. Metab Brain Dis 2017;32:743–9.10.1007/s11011-017-9963-xSearch in Google Scholar PubMed

48. Sadia, P, Haroon, K, Aini, P. Plant alkaloids as an emerging therapeutic alternative for the treatment of depression. Front Pharmacol 2016;7:28. https://doi.org/10.3389/fphar.2016.00028.Search in Google Scholar PubMed PubMed Central

49. Jeanette, M, Brijesh, S. Phytochemistry and pharmacology of anti-depressant medicinal plants: a review. Biomed Pharmacother 2018;104:343–65.10.1016/j.biopha.2018.05.044Search in Google Scholar PubMed

Received: 2021-07-20
Revised: 2021-12-17
Accepted: 2021-12-30
Published Online: 2022-02-24

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 19.5.2024 from https://www.degruyter.com/document/doi/10.1515/dmpt-2021-0166/html
Scroll to top button